Takeda Pharmaceutical Co., Ltd. (TAK)
18.34
+0.10
(+0.58%)
USD |
NYSE |
Aug 25, 16:00
18.34
0.00 (0.00%)
After-Hours: 16:03
Takeda Pharmaceutical EPS Diluted (Quarterly) : 0.2213 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2213 |
| March 31, 2026 | -0.7433 |
| December 31, 2025 | 0.2099 |
| September 30, 2025 | -0.0253 |
| June 30, 2025 | 0.2706 |
| March 31, 2025 | -0.2144 |
| December 31, 2024 | 0.0478 |
| September 30, 2024 | 0.1915 |
| June 30, 2024 | 0.1923 |
| March 31, 2024 | -0.0065 |
| December 31, 2023 | 0.2255 |
| September 30, 2023 | -0.1061 |
| June 30, 2023 | 0.2077 |
| March 31, 2023 | 0.0729 |
| December 31, 2022 | 0.2682 |
| September 30, 2022 | 0.1427 |
| June 30, 2022 | 0.2602 |
| March 31, 2022 | -0.0314 |
| December 31, 2021 | 0.1613 |
| September 30, 2021 | 0.1321 |
| June 30, 2021 | 0.3997 |
| March 31, 2021 | 0.5902 |
| December 31, 2020 | 0.2804 |
| September 30, 2020 | 0.0121 |
| June 30, 2020 | 0.245 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0049 |
| December 31, 2019 | -0.0951 |
| September 30, 2019 | 0.202 |
| June 30, 2019 | 0.0204 |
| March 31, 2019 | -0.0854 |
| December 31, 2018 | 0.2124 |
| September 30, 2018 | 0.2758 |
| June 30, 2018 | 0.4557 |
| March 31, 2018 | -0.3192 |
| December 31, 2017 | 0.3835 |
| September 30, 2017 | 0.1607 |
| June 30, 2017 | 0.8296 |
| March 31, 2017 | -0.2861 |
| December 31, 2016 | 0.2408 |
| September 30, 2016 | 0.1544 |
| June 30, 2016 | 0.5873 |
| March 31, 2016 | -0.1855 |
| December 31, 2015 | 0.3088 |
| September 30, 2015 | 0.1543 |
| June 30, 2015 | 0.1281 |
| March 31, 2015 | -1.204 |
| December 31, 2014 | 0.1015 |
| September 30, 2014 | 0.1712 |
| June 30, 2014 | 0.2074 |
| March 31, 2014 | -0.1272 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Ono Pharmaceutical Co., Ltd. | 0.1075 |
| Astellas Pharma, Inc. | 0.4955 |
| Sanofi | -- |
| Eisai Co., Ltd. | 0.1015 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 710.72M |
| Revenue (Quarterly) | 7.655B |
| Total Expenses (Quarterly) | 6.945B |
| Enterprise Value | 85.21B |
| Gross Profit Margin (Quarterly) | 57.57% |
| Profit Margin (Quarterly) | 9.28% |
| Earnings Yield | -1.84% |
| Operating Earnings Yield | 7.83% |
| Normalized Earnings Yield | -0.9780 |